Post-healing Follow-up Study in People With Remission of a Diabetic Foot Ulcer (Pied-REM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04892771|
Recruitment Status : Recruiting
First Posted : May 19, 2021
Last Update Posted : June 2, 2021
|Condition or disease|
Diabetic foot ulcer is a major world health problem with a very high recurrence rate, 50% at two years.
The main causes of diabetic foot ulcer recurrence are inadequate footwear, lack of podology care and lack of self-care. International recommendations call for regular podological monitoring to prevent recurrence of diabetic foot ulcer.
The "remission foot" consultation assesses recommended items and is offered to any healed patient at the rate of two annual visit.
A retrospective study on multidisciplinary specific follow-up may show a real efficacity on recurrence rate.
|Study Type :||Observational|
|Estimated Enrollment :||158 participants|
|Official Title:||Post-healing Follow-up Study in People With Remission of a Diabetic Foot Ulcer|
|Estimated Study Start Date :||June 1, 2021|
|Estimated Primary Completion Date :||June 1, 2022|
|Estimated Study Completion Date :||September 1, 2022|
Patients who have honored two consultations per year for two years.
Patients who have not honored two consultations per year for two years.
- Number of wound [ Time Frame: At 2 years ]Diabetic foot ulcer recurrence
- Hospitalisation [ Time Frame: At 2 years ]Days of hospitalisation for diabetic foot ulcer
- Number of visits to the pedicure [ Time Frame: At 2 years ]Podology follow-up
- Adequate footwear [ Time Frame: At 2 years ]Wearing of adequate shoes
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04892771
|Contact: Marie BOULY, APN (Advanced Practice Nurse)||(33) firstname.lastname@example.org|
|Contact: Caroline TOURTE||(33) 1 61 69 31 email@example.com|
|Centre Hospitalier Sud Francilien||Recruiting|
|Corbeil-Essonnes, France, 91100|
|Contact: Marie BOULY, APN (33) 188.8.131.52.04 firstname.lastname@example.org|